Viewing Study NCT03861403

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:47 PM
Ignite Modification Date: 2026-03-09 @ 4:50 PM
Study NCT ID: NCT03861403
Status: TERMINATED
Last Update Posted: 2023-11-30
First Post: 2019-02-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors
Sponsor: Leap Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumors View
None Advanced Triple Negative Breast Cancer View
None Advanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer View
None Advanced Metastatic Castration-Resistant Prostate Cancer View
None Advanced Platinum-Resistant Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic View
None Stage III or IV View
None Recurrent View
None Refractory View
None Solid tumors View
None Breast cancer View
None Prostate cancer View
None Ovarian cancer View